文献速递冠心病心力衰竭与心肌病

经皮冠状动脉介入治疗对心力衰竭患者结局的影响:JACC最新综述

Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

冠状动脉疾病在心力衰竭患者中非常普遍,约占三分之二病例。观察性研究提示经皮冠状动脉介入治疗(PCI)使用增加且可能与结局改善相关,但缺乏比较PCI与冠状动脉旁路移植术或指南导向药物治疗的随机数据。本综述描述了PCI在急性心衰、慢性射血分数降低心衰和射血分数保留心衰中的现有证据,并呼吁开展充分效能的随机临床试验。

要点

  • 冠脉疾病约占心衰病例的三分之二
  • PCI在心衰合并冠脉疾病患者中使用明显增加
  • 缺乏比较PCI与CABG或指南导向药物治疗的随机数据

核心结论

  • PCI在心衰合并冠脉疾病患者中使用增加且观察性研究提示结局改善,但缺乏随机对照数据。

研究设计与样本

  • 本文为JACC最新综述,描述PCI在急性心衰、慢性射血分数降低心衰和射血分数保留心衰中的现有证据。

主要发现

  • 冠状动脉疾病在心力衰竭患者中非常普遍,约占三分之二病例。
  • PCI在心衰合并冠脉疾病患者中使用明显增加,多项观察性研究提示与结局改善相关。
  • 缺乏比较PCI与冠状动脉旁路移植术或当代指南导向药物治疗对临床结局和心肌恢复影响的随机数据。

局限性

  • 缺乏比较PCI与冠状动脉旁路移植术或指南导向药物治疗的随机数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronary artery disease (CAD) is highly prevalent in patients with heart failure (HF) and accounts for nearly two-thirds of cases. The use of percutaneous coronary intervention (PCI) in HF patients with CAD has markedly increased and has been suggested to be associated with improved outcomes in numerous observational studies. Randomized data comparing the impact of PCI with that of coronary artery bypass graft (CABG) or contemporary guideline-directed medical therapy alone on clinical outcomes and myocardial recovery in patients with HF are lacking. The purpose of this review is to describe the available evidence regarding the impact of PCI in acute HF (in the presence and absence of an acute coronary syndrome), chronic HF with reduced ejection fraction, and HF with preserved ejection fraction. Adequately-powered randomized clinical trials examining the outcomes with PCI in these distinct HF populations are warranted.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Parikh PB, Bhatt DL, Bhasin V, et al. Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 33985688. doi:10.1016/j.jacc.2021.03.310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。